We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$138M
AUM Growth
-$9.31M
Cap. Flow
-$9.71M
Cap. Flow %
-7.03%
Top 10 Hldgs %
24.49%
Holding
191
New
28
Increased
25
Reduced
77
Closed
34

Top Buys

Rank Stock Value
1
TSN icon
Tyson Foods
TSN
+$935K
2
MET icon
MetLife
MET
+$903K
3
FOX icon
Fox Class B
FOX
+$867K
4
CAG icon
Conagra Brands
CAG
+$770K
5
ELAN icon
Elanco Animal Health
ELAN
+$663K

Sector Composition

Rank Sector Weight
1 Healthcare 18.53%
2 Consumer Staples 15.56%
3 Industrials 14.75%
4 Technology 13.52%
5 Financials 12.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHD icon
1
Church & Dwight Co
CHD
$23.4B
$5.78M 4.18%
76,775
-975
-1% -$73.9K
JNJ icon
2
Johnson & Johnson
JNJ
$618B
$4.49M 3.25%
34,727
+1,900
+6% +$250K
CSCO icon
3
Cisco
CSCO
$457B
$4.26M 3.08%
86,150
+2,750
+3% +$143K
WASH icon
4
Washington Trust Bancorp
WASH
$743M
$3.44M 2.49%
71,198
-974
-1% -$47.6K
INTC icon
5
Intel
INTC
$455B
$3.18M 2.3%
61,662
+725
+1% +$35.6K
KMB icon
6
Kimberly-Clark
KMB
$36.3B
$2.95M 2.14%
20,788
DIS icon
7
Walt Disney
DIS
$167B
$2.79M 2.02%
21,430
-550
-3% -$76.1K
AAPL icon
8
Apple
AAPL
$4.54T
$2.48M 1.79%
44,236
-940
-2% -$49.1K
KO icon
9
Coca-Cola
KO
$377B
$2.25M 1.63%
41,325
ZTS icon
10
Zoetis
ZTS
$32.4B
$2.19M 1.59%
17,573
-500
-3% -$60.4K
ABT icon
11
Abbott
ABT
$183B
$2.11M 1.53%
25,178
-200
-0.8% -$17K
MSFT icon
12
Microsoft
MSFT
$3.45T
$2.05M 1.48%
14,734
-200
-1% -$27.5K
PFE icon
13
Pfizer
PFE
$143B
$1.99M 1.44%
58,269
+6,745
+13% +$245K
MRK icon
14
Merck
MRK
$322B
$1.96M 1.42%
24,413
-472
-2% -$37.8K
XOM icon
15
ExxonMobil
XOM
$644B
$1.78M 1.29%
25,261
-200
-0.8% -$14.5K
CVS icon
16
CVS Health
CVS
$133B
$1.77M 1.28%
28,000
-6,950
-20% -$412K
UPS icon
17
United Parcel Service
UPS
$88.6B
$1.72M 1.25%
14,350
-1,426
-9% -$163K
CSX icon
18
CSX Corp
CSX
$93.4B
$1.68M 1.22%
72,825
PG icon
19
Procter & Gamble
PG
$336B
$1.68M 1.22%
13,526
-50
-0.4% -$5.91K
BMY icon
20
Bristol-Myers Squibb
BMY
$133B
$1.66M 1.2%
32,687
-350
-1% -$16.4K
VZ icon
21
Verizon
VZ
$195B
$1.47M 1.07%
24,370
+5,100
+26% +$294K
BRK.B icon
22
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.44M 1.04%
6,911
-75
-1% -$15.5K
LLY icon
23
Eli Lilly
LLY
$1.02T
$1.44M 1.04%
12,850
+3,650
+40% +$406K
NKE icon
24
Nike
NKE
$61.9B
$1.4M 1.02%
14,935
-100
-0.7% -$8.58K
IBM icon
25
IBM
IBM
$211B
$1.37M 0.99%
9,874
-53
-0.5% -$7.15K

Similar funds

New England Research & Management's Q3 2019 Portfolio in Review

As of Q3 2019, New England Research & Management held 191 positions worth $138M, down 6.3% from $147M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

New England Research & Management withdrew a net $9.71M in Q3 2019, closing 34 positions and reducing 77 holdings. Its most notable exit was Amgen, an estimated $1.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Consumer Staples and Industrials.

Against the trend, New England Research & Management opened a new position in Tyson Foods worth $948K.

  • New England Research & Management's largest Q3 2019 buy was Tyson Foods: 11,000 shares worth $948K.
  • New England Research & Management added most to Elanco Animal Health in Q3 2019, an estimated $663K increase.
  • New England Research & Management's biggest Q3 2019 reduction was Estee Lauder, cutting an estimated $1.41M.
  • New England Research & Management fully exited Amgen in Q3 2019, selling an estimated $1.8M.
  • New England Research & Management's ten largest holdings make up 24% of its $138M portfolio in Q3 2019.
  • New England Research & Management opened 28 new positions and closed 34 in Q3 2019.
  • New England Research & Management's portfolio value fell 6.3% quarter-over-quarter to $138M.

Based on New England Research & Management's 13F filing for Q3 2019, filed 4 Nov 2019.